S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Monterey Bio Acquisition Stock Forecast, Price & News

0.00 (0.00%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1 shs
Average Volume
6,784 shs
Market Capitalization
$144.09 million
P/E Ratio
Dividend Yield
Price Target

Monterey Bio Acquisition Stock Forecast (MarketRank)

Analyst Rating
Short Interest
0.00% of Shares Sold Short
Dividend Strength
News Sentiment
1.44mentions of Monterey Bio Acquisition in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.77 out of 5 stars

Unclassified Sector

376th out of 724 stocks

Holding & Other Investment Offices Industry

361st out of 682 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive MTRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Monterey Bio Acquisition and its competitors with MarketBeat's FREE daily newsletter.

About Monterey Bio Acquisition

Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.

MTRY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Holding & other investment offices
Current Symbol
Year Founded

Company Calendar

Fiscal Year End


Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$0.06 per share


Free Float
Market Cap
$144.09 million
Not Optionable

Monterey Bio Acquisition Frequently Asked Questions

How has Monterey Bio Acquisition's stock performed in 2022?

Monterey Bio Acquisition's stock was trading at $9.85 on January 1st, 2022. Since then, MTRY shares have increased by 1.7% and is now trading at $10.02.
View the best growth stocks for 2022 here

Who are Monterey Bio Acquisition's key executives?

Monterey Bio Acquisition's management team includes the following people:
  • Dr. Sanjeev Satyal Ph.D., Chief Exec. Officer (Age 52)
  • Mr. William McKeever, CFO & Director (Age 66)

What is Monterey Bio Acquisition's stock symbol?

Monterey Bio Acquisition trades on the NASDAQ under the ticker symbol "MTRY."

How do I buy shares of Monterey Bio Acquisition?

Shares of MTRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Monterey Bio Acquisition's stock price today?

One share of MTRY stock can currently be purchased for approximately $10.02.

How much money does Monterey Bio Acquisition make?

Monterey Bio Acquisition (NASDAQ:MTRY) has a market capitalization of $144.09 million.

How many employees does Monterey Bio Acquisition have?

Monterey Bio Acquisition employs 2,021 workers across the globe.

How can I contact Monterey Bio Acquisition?

Monterey Bio Acquisition's mailing address is 17 STATE STREET 21ST FLOOR, NEW YORK NY, 10004. The official website for Monterey Bio Acquisition is www.montereybio.com. The company can be reached via phone at 917-267-0216.

This page (NASDAQ:MTRY) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.